Newly-released Orthopedic Navigation Systems Market analysis report by Future Market Insights shows that global sales of the Orthopedic Navigation Systems Market in 2022 were held at USD 2.4 Billion. With a CAGR of 16.9% from 2023 to 2033, the market is projected to reach a valuation of USD 13.2 Billion. Orthopedic navigation systems for Knee is expected to be the highest revenue-generating segment, accounting for an expected CAGR rate of 19.1% from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Orthopedic Navigation Systems Market (2023) | USD 2.8 Billion |
| Global Orthopedic Navigation Systems Market (2033) | USD 13.2 Billion |
| Global Orthopedic Navigation Systems Market CAGR (2023 to 2033) | 16.9% |
| USA Orthopedic Navigation Systems Market CAGR (2023 to 2033) | 17.6% |
| Key Companies Profiled | Stryker; Medtronic; Johnson & Johnson Services; B. Braun Melsungen AG; Smith + Nephew; OrthAlign; Globus Medical; Zimmer Biomet |
Explore FMI!
Book a free demo
As per the Orthopedic Navigation Systems Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at around 15% CAGR.
More than a decade ago, orthopedic navigation systems were first employed in orthopedic spinal surgery to improve the efficiency of pedicle screw insertion. It has now received widespread acceptance among orthopedic surgeons and has shown to be a useful tool in a variety of orthopedic operations, including reconstructive hip and knee surgery, sports injury, trauma, spine surgery, and tumor surgery.
Orthopedic navigation systems are developed to provide surgeons with real-time input on the surgical field, allowing them to change surgical approaches in order to improve postoperative outcomes and reduce intraoperative errors. Furthermore, classic and conventional approaches may lack accuracy, precision, and repeatability. As a result, there is a greater need for the creation of a revolutionary orthopedic navigation system.
Over the forecast years, the market is expected to rise due to an increase in the senior population and cases of joint reconstruction, rising healthcare expenditure, and high levels of awareness among patients and healthcare professionals. The prevalence of orthopedic disorders such as osteoarthritis, osteoporosis, ligamentous knee injuries, and rheumatoid arthritis, is on the rise.
Muscles, bones, joints, nerves, ligaments, cartilage, and tendons are all part of the musculoskeletal system, which includes bones, muscles, nerves, joints, ligaments, tendons, and cartilage. This causes a loss in the range of motion, stiffness, edema, and muscle soreness, which necessitates surgical intervention later.
Factors such as the rising use of minimally invasive surgical procedures, the increasing number of mergers and acquisitions among market participants, and the rising incidence of orthopedic and neurological illnesses are driving the orthopedic navigation systems market.
Increasing financing initiatives from the government for surgical navigation system research and development is also contributing to market growth. The high cost of surgical navigation systems and product recalls, on the other hand, are anticipated to have a negative impact on the orthopedic navigation systems market's growth.
Businesses are concentrating on raising knowledge about the use and benefits of orthopedic navigation systems among healthcare professionals and patients. In developed countries, manufacturers of surgical navigation systems have begun to reach out to local communities by offering CME classes. As a result, physicians and experts are becoming more aware of the availability and use of orthopedic navigation systems. Furthermore, commercially marketed orthopedic navigation systems come with a six to seven-year warranty, resulting in a seven-year product sales cycle. As a result of the increased demand for technology aid in orthopedic treatments, the market for orthopedic navigation systems is likely to expand throughout the forecast period.
Several innovative technologies are currently projected to impact the market in the near future. As a result, in the next seven years, hospitals are more likely to hunt for better alternatives. Owing to this, hospitals can avoid purchasing an orthopedic navigation system multiple times. Due to this, orthopedic navigation system providers are unable to reach new clients, hampering market expansion.
It is likely that one of the primary factors projected to boost the growth and demand of the orthopedic navigation systems market is the increased use of navigation software by physicians and surgeons due to the availability of cost-effective solutions. Furthermore, from 2023 to 2033, the rising adoption of minimally invasive operations and increased awareness are likely to contribute to the global market's growth.
The rising rate of obesity-related disorders and the large numbers of patients who value computer-assisted surgery will drive market growth. In addition, the launch of the new technology is predicted to fuel the expansion of the high-growth zone of the additional joint reconstruction market.
In the forecast period of 2023 to 2033, rapid technological advances in surgical navigation systems, the acquisition of capital for research and development activities, and growth in the incidence of osteoarthritis are expected to provide lucrative opportunities for the orthopedic navigation systems market.
In 2022, North America accounted for a significant revenue share due to favorable government measures promoting orthopedic navigation systems. Furthermore, factors such as an aging population, high government healthcare spending, a well-developed reimbursement mechanism, and the existence of established manufacturers in the region all contribute to regional market growth.
The high rate of occurrence of osteoarthritis in countries, as well as technical improvements in the United States, have contributed to the growth of the orthopedic navigation systems market in North America.
Between 2012 and 2018, 1,525,435 primary and revision hip and knee arthroplasty surgeries were performed, according to the 2019 American Joint Replacement Registry Annual Report. With 55.1% and 33.1%, most surgeries were for the primary knee and primary hip, respectively. The average age of a hip arthroplasty patient was 67.4 years, whereas the average age of all knee arthroplasty patients was 66.7 years, indicating the patient population in North America.
USA accounts for a significant share of the market and is expected to account for a valuation of USD 5.2 Billion by 2033. Complete knee arthroplasty, total hip arthroplasty, anterior cruciate ligament restoration, trauma, and corrective surgeries use orthopedic imaging-guided surgical systems.
The positioning of the orthopedic implant is critical throughout these repair surgeries. Despite being dominated by a few well-established companies, the industry in the United States continues to grow thanks to surgeons and medical institutes promoting applications for the spine, nose and throat, and orthopedics.
The market in the United Kingdom is expected to reach a valuation of USD 1.1 Billion by 2033. Growing with a CAGR of 15.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around USD 715.9 Million.
In Japan, the market is expected to grow at a CAGR of 19.2% from 2023 to 2033, reaching around USD 539 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of USD 444.6 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around USD 207 Million by 2033, growing at a CAGR of 12% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around USD 142.3 Million.
The market revenue through Knee application is expected to account for a CAGR of 19.1% during the forecast period. Rising awareness pertaining to the advantages associated with total knee replacement procedures and improved patient well-being has resulted in the rise of total knee replacement procedures.
Segment growth on multiple surgical fronts can be credited to increasing applications of total knee arthroplasty, unicompartmental knee replacement, kneecap replacement, and revision knee replacement procedures.
Advancements in medical technology, such as the development of minimally invasive operations, and the increased availability of superior implant materials are likely to drive the increased volume of knee-replacement operations, boosting segment growth.
Knee replacement surgeries have increased globally due to the rising incidence of knee disorders and growing unhealthy lifestyles. Additionally, the use of orthopedic navigation as well as surgical techniques that could speed up navigation is likely to accelerate the need for navigation systems in knee replacement surgeries.
Optical orthopedic navigation systems hold a prominent market share and are expected to account for a CAGR of 16.7% from 2023 to 2033. Since Optical Navigation Systems are easy to handle and manage Intra operative instances as compared to conventional surgical systems. Furthermore, these systems operate at maximum precision and are more reliable.
This has improved surgical technical operations and paved the way for more complex treatments. When compared to older surgical systems, an optical surgical navigation system is simple to use. Furthermore, it is based on a highly precise stereo-vision approach. These systems are used in medical treatments that need a high level of precision and several access points. The expansion of the segment can be attributable to such technological advantages.
The key players operating in Orthopedic Navigation Systems Market include Stryker, Medtronic, Johnson & Johnson Services, B. Braun Melsungen AG, Smith + Nephew, OrthAlign, Globus Medical, and Zimmer Biomet.
Similarly, recent developments related to companies offering Orthopedic Navigation Systems have been tracked by the team at Future Market Insights, which are available in the full report.
The market is valued at USD 2.8 billion in 2023.
The market is estimated to flourish at a 16.9% CAGR through 2033.
Japan to surge at a CAGR of 19.2% through 2033.
Top market players are Stryker, Medtronic, and Johnson & Johnson Services.
The market is estimated to reach USD 13.2 billion in 2033.
Home Respiratory Therapy Market – Growth & Forecast 2025 to 2035
Generalized Myasthenia Gravis Management Market - Growth & Treatment Advances 2025 to 2035
Hutchinson-Gilford Progeria Syndrome Market Growth – Innovations & Therapies 2025 to 2035
Home Infusion Therapy Devices Market - Growth & Forecast 2025 to 2035
Human Combinatorial Antibody Libraries (HuCAL) Market - Trends & Forecast 2025 to 2035
Home Healthcare Market Growth - Trends, Innovations & Forecast 2025 to 2035
Orthopedic Navigation Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
